Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.10+0.00 (+2.40%)
Close on Nov 13, 2026Market cap $1.97MP/E –Yield –
Vivos Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Vivos Therapeutics's enterprise value was $7.51M on Nov 11, 2026, against $24.31M a year earlier. Over the last 5 years it ranged from $1.10M to $54.10M, with a median of $11.61M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $7.51M | -66.5% |
| 2025 | Dec 31, 2025 | $22.41M | +46.2% |
| 2024 | Dec 31, 2024 | $15.33M | +1.5% |
| 2023 | Dec 29, 2023 | $15.11M | +496.6% |
| 2022 | Dec 30, 2022 | $2.53M | -89.7% |
| 2021 | Dec 31, 2021 | $24.51M | -68.1% |
| 2020 | Dec 31, 2020 | $76.79M | – |
See a number that looks wrong?